Angiogenic synergism, vascular stability and improvement of hind-limb ischemia by a combination of PDGF-BB and FGF-2
about
Response gene to complement 32, a novel hypoxia-regulated angiogenic inhibitorSpatiotemporal control over growth factor signaling for therapeutic neovascularizationThe progress of angiogenic factors in the development of leukemiasRole of platelet-rich plasma in ischemic heart disease: An update on the latest evidenceBiologic Agents for Periodontal Regeneration and Implant Site DevelopmentInternal ribosome entry site-based vectors for combined gene therapyRedox balance dynamically regulates vascular growth and remodelingDevelopment and validation of an automated high-throughput system for zebrafish in vivo screeningsImproved Angiogenesis in Response to Localized Delivery of Macrophage-Recruiting MoleculesMR angiography of collateral arteries in a hind limb ischemia model: comparison between blood pool agent Gadomer and small contrast agent Gd-DTPASemaphorin 3E initiates antiangiogenic signaling through plexin D1 by regulating Arf6 and R-Ras.N-CAM exhibits a regulatory function in pathological angiogenesis in oxygen induced retinopathyA MicroRNA93-Interferon Regulatory Factor-9-Immunoresponsive Gene-1-Itaconic Acid Pathway Modulates M2-Like Macrophage Polarization to Revascularize Ischemic Muscle.Targeted delivery of nanoparticles bearing fibroblast growth factor-2 by ultrasonic microbubble destruction for therapeutic arteriogenesis.The WNT antagonist Dickkopf2 promotes angiogenesis in rodent and human endothelial cells.Nitrite anion stimulates ischemic arteriogenesis involving NO metabolism.Fibroblast growth factor 9 delivery during angiogenesis produces durable, vasoresponsive microvessels wrapped by smooth muscle cells.VEGF, FGF1, FGF2 and EGF gene polymorphisms and psoriatic arthritis.PDGF-C mediates glomerular capillary repair.Phase 1 study of lenvatinib combined with carboplatin and paclitaxel in patients with non-small-cell lung cancer.Clinical and immunological markers of dengue progression in a study cohort from a hyperendemic area in MalaysiaIRES-based vector coexpressing FGF2 and Cyr61 provides synergistic and safe therapeutics of lower limb ischemia.Sustained release of multiple growth factors from injectable polymeric system as a novel therapeutic approach towards angiogenesis.Increased perfusion and angiogenesis in a hindlimb ischemia model with plasmid FGF-2 delivered by noninvasive electroporation.Suppression of prostate cancer nodal and systemic metastasis by blockade of the lymphangiogenic axisModulation of stem cell differentiation with biomaterials.VEGFR1-mediated pericyte ablation links VEGF and PlGF to cancer-associated retinopathy.Neurotrophins promote revascularization by local recruitment of TrkB+ endothelial cells and systemic mobilization of hematopoietic progenitors.Dual delivery of VEGF and MCP-1 to support endothelial cell transplantation for therapeutic vascularizationSkeletal myofiber VEGF is essential for the exercise training response in adult miceMolecular mechanisms of resistance to tumour anti-angiogenic strategiesFast growth associated with aberrant vasculature and hypoxia in fibroblast growth factor 8b (FGF8b) over-expressing PC-3 prostate tumour xenografts.Clinicopathological significance of platelet-derived growth factor (PDGF)-B and vascular endothelial growth factor-A expression, PDGF receptor-β phosphorylation, and microvessel density in gastric cancer.Disorganized vascular structures in sporadic venous malformations: a possible correlation with balancing effect between Tie2 and TGF-β.Challenging the surgical rodent hindlimb ischemia model with the miniinterventional techniquePDGF-CC blockade inhibits pathological angiogenesis by acting on multiple cellular and molecular targets.Current state and perspective on medical treatment of critical leg ischemia: gene and cell therapy.Ectopic expression of human acidic fibroblast growth factor 1 in the medicinal plant, Salvia miltiorrhiza, accelerates the healing of burn wounds.Human peripheral blood-derived CD31+ cells have robust angiogenic and vasculogenic properties and are effective for treating ischemic vascular disease.Vascular smooth cell proliferation in perfusion culture of porcine carotid arteries
P2860
Q24320745-CE3DF982-3448-43DE-9649-84F24BFE2687Q24641819-D6353F45-9234-4687-A7ED-330F1847E540Q26753835-1EDD9B94-6E81-40BC-894D-22475D4F955FQ26777855-27318595-7AAD-4D60-B28E-50FDBB52113DQ26778208-8218BD69-F871-42E0-831E-C87951A53678Q26866358-08752369-7F68-4C76-AC92-A38F9A781E5FQ27004547-6139AEF6-7509-48E1-8067-38F45B7A413BQ27303272-7EE08D11-9355-4D26-98DF-8DE0DAF64494Q27303518-9F073E1F-A5B3-4002-AB7F-9A909D663EEEQ27437647-DF6DE84A-C2C9-4BF1-9818-0B5D426F159EQ28593676-D7E1C127-802F-4571-B73B-9A24E32D5A06Q28743741-C60209C3-E86D-4AD5-AF7C-94ADC666F132Q30252768-3968A894-0897-4BE9-BF0C-D2A67D75D9D5Q30438396-6BD6466A-B58B-4D44-9EE4-4E3279DF9C4EQ30499919-0E873B12-A45A-46FA-BD8B-74746432838AQ30522302-A1CC796C-5104-463C-8A7D-61E26E37BDA9Q31005484-0C7E952A-8297-4FA5-8C36-9CBE1FAC43F4Q33268240-C82C7043-613D-43B4-BE3D-CA7DA992592DQ33389716-E8EF1A99-F9D9-4C80-988F-B5D359DE09E7Q33409140-64CDC6E1-B86E-409D-83EF-F3A8A1EC0452Q33414050-81806C1C-9CAA-4007-8AF0-A3D02F9AEF7BQ33500964-C48F3353-CE6F-412E-BAB5-8FE23FC28C03Q33517020-CE9329BE-0E1D-4782-9F88-E34CE59C8C87Q33555860-83BEF67A-7386-4C32-B7AC-83173B264AA8Q33565805-1236D7DB-4860-4AE0-B59E-1952B399A132Q33614866-4F638D18-0851-46D0-B245-6F941CA6CE3AQ33640270-9506139D-CFBF-4300-8584-0A42F260D90CQ33683715-33A4675A-ECAE-42CD-9144-86987409C7BFQ33684402-FC99F5F3-C34B-49CC-95E9-16210435EEB1Q33704850-525E410A-41C5-405F-9DFA-8AD34237A810Q33718025-B7A15600-AAE0-4700-B0F1-D877EC3CB4ECQ33733638-5DA4664B-098D-4A6A-9EAD-5BB9A1634E30Q33759177-CEAB6D2E-A9D7-47BA-8C65-48778E560BA8Q33807944-41BBF5D7-977F-424D-B475-5244F2075437Q33861027-A414AB0A-9ACB-4534-A84E-F7E8AF881CF5Q33981871-38C5414A-02C7-4CF1-B0FB-49AD14A7BFE8Q33991426-23F8254E-487B-44BA-8C03-35F7D5ED1362Q34050193-E4D0E269-3513-4CD2-9387-361AB8F11511Q34051561-C5BCB951-267B-4B88-A1C6-5861012B2AEBQ34078609-EA9CCFFD-BC53-4F5C-98E1-2A7A4D5BCE45
P2860
Angiogenic synergism, vascular stability and improvement of hind-limb ischemia by a combination of PDGF-BB and FGF-2
description
2003 nî lūn-bûn
@nan
2003 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Angiogenic synergism, vascular ...... mbination of PDGF-BB and FGF-2
@ast
Angiogenic synergism, vascular ...... mbination of PDGF-BB and FGF-2
@en
Angiogenic synergism, vascular ...... mbination of PDGF-BB and FGF-2
@nl
type
label
Angiogenic synergism, vascular ...... mbination of PDGF-BB and FGF-2
@ast
Angiogenic synergism, vascular ...... mbination of PDGF-BB and FGF-2
@en
Angiogenic synergism, vascular ...... mbination of PDGF-BB and FGF-2
@nl
prefLabel
Angiogenic synergism, vascular ...... mbination of PDGF-BB and FGF-2
@ast
Angiogenic synergism, vascular ...... mbination of PDGF-BB and FGF-2
@en
Angiogenic synergism, vascular ...... mbination of PDGF-BB and FGF-2
@nl
P2093
P3181
P356
P1433
P1476
Angiogenic synergism, vascular ...... mbination of PDGF-BB and FGF-2
@en
P2093
David Wariaro
Eric Wahlberg
Mark J Post
Renhai Cao
Robert Pawliuk
P2888
P304
P3181
P356
10.1038/NM848
P407
P577
2003-03-31T00:00:00Z